Linagliptin Sandoz 5 mg
Linagliptin Sandoz 5 mg is a medicine authorised by Swissmedic under authorisation number 70156. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 13 November 2025 and the authorisation is limited until 12 November 2030. ATC code A10BH05 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 70156 |
|---|---|
| Name | Linagliptin Sandoz 5 mg |
| Full name | Linagliptin Sandoz 5 mg, Filmtabletten |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10BH05 |
| First authorisation | 13 November 2025 |
| Authorisation validity | 12 November 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Linagliptin Sandoz 5 mg, Filmtabletten | B | 13 November 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | A10BH05 | 07.06.2. | B |
| 2 | 90 | Tablette(n) | A10BH05 | 07.06.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Linagliptin Sandoz 5 mg authorised in Switzerland?
Yes. Linagliptin Sandoz 5 mg is authorised by Swissmedic under authorisation number 70156, data as of 01 September 2026. The authorisation is limited until 12 November 2030.
Which dispensing category does Linagliptin Sandoz 5 mg have?
Linagliptin Sandoz 5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Linagliptin Sandoz 5 mg?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.